A multifunctional drug delivery system consisting of a lipid-based nanoparticle, a standard anticancer drug, and a short nucleic acid designed to augment the activity of that drug has demonstrated the ability to treat drug-resistant tumor cells.
Two researchers working independently of one another have developed new methods for measuring the biological activity of nanomaterials in a highly systematic manner that enable them to draw important insights about nanomaterial biologic activity.
Researchers have identified the major mechanisms that cancer cells use to neutralize the cytotoxic, or cell-killing, effects of anticancer drugs, and now they are using nanotechnology to help derail drug resistance and improve the odds of successfully treating cancer.
Investors could make substantial returns over the next five to 10 years by investing in companies working in the field of medical nanotechnology, a report on the fledgling sector published Thursday said.
The Taiwan Nano Exhibition, the second largest of its kind in Asia, kicked off in Taipei yesterday, showcasing Taiwan's latest nano applications and products and gearing up to attract some 10,000 visitors.
RSC Publishing has today announced two new journals for 2009: Integrative Biology and Metallomics. Authors will welcome these titles as they fill the interdisciplinary gaps in the worldwide scientific publishing community.
It seems that reality is catching up with science fiction fast. On TV, the latest Knight Rider series features a car that embraces nanotechnology to change colors and morph into similar car forms temporarily. Yesterday, BMW introduced it's GINA Light Visionary Model.